Coromandel International Ltd
NSE:COROMANDEL
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1 039.5
1 862.7
|
| Price Target |
|
We'll email you a reminder when the closing price reaches INR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Coromandel International Ltd
Coromandel International Ltd
Other Receivables
Coromandel International Ltd
Other Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Coromandel International Ltd
NSE:COROMANDEL
|
Other Receivables
₹17.1B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
|
UPL Ltd
NSE:UPL
|
Other Receivables
₹4.8B
|
CAGR 3-Years
62%
|
CAGR 5-Years
13%
|
CAGR 10-Years
N/A
|
|
|
Fertilisers And Chemicals Travancore Ltd
NSE:FACT
|
Other Receivables
₹1.7B
|
CAGR 3-Years
105%
|
CAGR 5-Years
62%
|
CAGR 10-Years
N/A
|
|
|
Bayer Cropscience Ltd
NSE:BAYERCROP
|
Other Receivables
₹926m
|
CAGR 3-Years
-14%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
|
Sumitomo Chemical India Ltd
NSE:SUMICHEM
|
Other Receivables
₹2.5B
|
CAGR 3-Years
149%
|
CAGR 5-Years
75%
|
CAGR 10-Years
N/A
|
|
|
PI Industries Ltd
NSE:PIIND
|
Other Receivables
₹37m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Coromandel International Ltd
Glance View
Coromandel International Ltd. emerges as a prominent player in the agri-solutions domain, deeply rooted in India's agricultural heartland. Established with the intent to bolster the farming community, Coromandel extends its reach across a series of verticals that ensure a robust value chain from manufacture to marketplace. The company excels in the production of fertilizers, marketing a diverse portfolio ranging from phosphatic to complex fertilizers, crafted to cater to the varying needs of the soil and crops. With a strategic focus on innovation, Coromandel also forays into specialty nutrients and crop protection solutions, which includes pesticides, fungicides, and other agri-protection products, fortifying crops against adversities and enhancing yield. This holistic approach not only fosters productivity for the farmers but significantly amplifies food security for the nation. Coromandel International’s operational model adeptly combines manufacturing prowess with a wide-reaching distribution network. The company leverages its advanced manufacturing facilities, which are strategically located to harness efficient supply chain logistics and optimize production capabilities. Meanwhile, Coromandel's extensive retail network, comprising numerous rural retail outlets, serves as the critical conduit to reach millions of farmers, offering not just products but also indispensable advice and services. This dual strategy—of ensuring high-quality product delivery while nurturing a strong, consultative relationship with the end-user farmers—creates a profitable loop. The farmers’ success translates into repeat business and a solidified market presence for Coromandel. As a result, the company's financial robustness is bolstered by this intricate synergy of production efficiency, market penetration, and relentless focus on agricultural enhancement.
See Also
What is Coromandel International Ltd's Other Receivables?
Other Receivables
17.1B
INR
Based on the financial report for Sep 30, 2024, Coromandel International Ltd's Other Receivables amounts to 17.1B INR.
What is Coromandel International Ltd's Other Receivables growth rate?
Other Receivables CAGR 10Y
0%
Over the last year, the Other Receivables growth was 14%. The average annual Other Receivables growth rates for Coromandel International Ltd have been -9% over the past three years , -6% over the past five years .
You don't have any saved screeners yet